Generic competition · all medicines · read 12 November 2026
Is there a generic of Betamethasone Dipropionate, and who makes it?
Betamethasone Dipropionate appears in 9 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 12 generic makers listed as marketed across them. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. Where both are dated, the first generic approval came between 2.4 and 18.8 years after the first brand approval. This is the Orange Book's listing, not a forecast.
Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.
- Betamethasone Dipropionate appears in 9 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 12 generic makers listed as marketed across them.
- 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
- Where both are dated, the first generic approval came between 2.4 and 18.8 years after the first brand approval.
- Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.
Cream, Topical
Four or more generic makers listed
Brand listed as marketed: Betamethasone Dipropionate. 5 generic makers with 5 generic products listed as marketed; the first generic approval is dated 3 February 1987.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Actavis Mid Atlantic Llc | 3 February 1987 | 1 |
| Sun Pharma Canada Inc | 30 April 1992 | 1 |
| Cosette Pharmaceuticals Nc Laboratories Llc | 12 October 2018 | 1 |
| Zydus Pharmaceuticals Usa Inc | 11 January 2019 | 1 |
| Aurobindo Pharma Ltd | 26 January 2026 | 1 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Lotion, Topical
One to three generic makers listed
Every brand product here is listed as discontinued. 3 generic makers with 3 generic products listed as marketed; the first generic approval is dated 31 July 1985.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Fougera Pharmaceuticals Inc | 12 August 1985 | 1 |
| Cosette Pharmaceuticals Nc Laboratories Llc | 10 August 1987 | 1 |
| Padagis Us Llc | 31 January 1990 | 1 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Ointment, Topical
Four or more generic makers listed
Brand listed as marketed: Betamethasone Dipropionate. 4 generic makers with 4 generic products listed as marketed; the first generic approval is dated 3 February 1987.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Actavis Mid Atlantic Llc | 3 February 1987 | 1 |
| Zydus Lifesciences Ltd | 14 July 2020 | 1 |
| Tp Anda Holdings Llc | 18 February 2022 | 1 |
| Padagis Israel Pharmaceuticals Ltd | 12 April 2022 | 1 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Cream, Augmented, Topical
One to three generic makers listed
Every brand product here is listed as discontinued. 3 generic makers with 3 generic products listed as marketed; the first generic approval is dated 9 December 2003.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Fougera Pharmaceuticals Inc | 9 December 2003 | 1 |
| Padagis Israel Pharmaceuticals Ltd | 9 December 2003 | 1 |
| Sun Pharma Canada Inc | 9 December 2003 | 1 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Ointment, Augmented, Topical
Four or more generic makers listed
Brand listed as marketed: Diprolene. 4 generic makers with 4 generic products listed as marketed; the first generic approval is dated 31 August 1995.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Actavis Mid Atlantic Llc | 31 August 1995 | 1 |
| Fougera Pharmaceuticals Inc | 22 June 1999 | 1 |
| Lupin Ltd | 18 December 2019 | 1 |
| Aurobindo Pharma Ltd | 10 April 2024 | 1 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Lotion, Augmented, Topical
One to three generic makers listed
Every brand product here is listed as discontinued. 3 generic makers with 3 generic products listed as marketed; the first generic approval is dated 21 May 2007.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Fougera Pharmaceuticals Inc | 21 May 2007 | 1 |
| Sun Pharma Canada Inc | 21 May 2007 | 1 |
| Encube Ethicals Private Ltd | 13 February 2018 | 1 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Gel, Augmented, Topical
One to three generic makers listed
Every brand product here is listed as discontinued. 2 generic makers with 2 generic products listed as marketed; the first generic approval is dated 13 May 2003.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Fougera Pharmaceuticals Inc | 13 May 2003 | 1 |
| Sun Pharma Canada Inc | 2 December 2003 | 1 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Spray, Topical
Brand listed, no generic listed as marketed
Brand listed as marketed: Sernivo. No generic is listed as marketed (1 generic product listed as discontinued).
Patents and exclusivities still listed
- 31 August 2030Patent 9775851 drug product
- 31 August 2030Patent 9364485 drug product
- 31 August 2030Patent 9655907 drug product
- 31 August 2030Patent 10179137 drug product
- 31 August 2030Patent 9433630 drug product
- 31 August 2030Patent 9877974 drug product
- 31 August 2030Patent 9439911 drug product
- 19 November 2045Patent 12661489
Disc, Topical
Nothing listed as marketed
Every brand product here is listed as discontinued. No generic is listed as marketed.
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.
Where can you go from this result?
Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.